Millennium Pharmaceuticals Inc acquires a minority stake in Prolysis Ltd


UK - Millennium Pharmaceuticals Inc of the US (MP) acquired an undisclosed minority stake in Prolysis Ltd, Kidlington-based discovery research software developer, from Oxford Molecular Group PLC (OMG). Concurrently, MP acquired the entire issued share capital of Cambridge Discovery Chemistry…

Deal Information

Credit & Investment Research

Market Research

News

Millennium Pharmaceuticals Inc Mergers & Acquisitions
Mahogany Acquisition Corp launches a tender offer for Millennium Pharmaceuticals Inc (5/14/2008 12:00:00 AM)
Millennium Pharmaceuticals Inc withdraws offer for AnorMED Inc (9/26/2006 12:00:00 AM)
Gene Logic Inc acquires Millennium Pharma-Tech Program from Millennium Pharmaceuticals Inc (7/23/2004 12:00:00 AM)
Millennium Pharmaceuticals Inc acquires COR Therapeutics Inc from Takeda Pharmaceutical Co Ltd (2/12/2002 12:00:00 AM)
Signature Bioscience Inc acquires Cambridge Discovery Chemistry from Millennium Pharmaceuticals Inc (7/16/2001 12:00:00 AM)
Abbott Laboratories Inc acquires a minority stake in Millennium Pharmaceuticals Inc (pending) (3/13/2001 12:00:00 AM)
Aventis Pharmaceuticals Inc acquires a minority stake in Millennium Pharmaceuticals Inc (7/28/2000 12:00:00 AM)
Millennium Pharmaceuticals Inc acquires Cambridge Discovery Chemistry from OM 2000 PLC (7/27/2000 12:00:00 AM)
Millennium Pharmaceuticals Inc acquires a minority stake in Cambridge Drug Discovery Ltd (7/27/2000 12:00:00 AM)
Millennium Pharmaceuticals Inc acquires remaining interest in Millennium Predictive Medicine (7/18/2000 12:00:00 AM)
More..